AG
GOSS icon

Artal Group’s Gossamer Bio GOSS Stock Holding History

Artal Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-207,000
Closed -$186K – 41
2024
Q2 		$186K Hold
207,000
– – ﹤0.01% 108
2024
Q1 		$244K Hold
207,000
– – 0.01% 110
2023
Q4 		$189K Buy
+207,000
New +$153K 0.01% 94

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Artal Group's GOSS Position: Q3 2024 in Review

Artal Group sold out of Gossamer Bio (GOSS) in Q3 2024, closing a stake of 13,308,968 shares — an estimated $12M sold.

Artal Group first reported a position in GOSS in Q1 2019 and held it in 22 quarters. The position peaked at $38.9M in Q3 2022. 100 funds tracked by Wall St. Rank hold GOSS as of Q3 2024.

  • Artal Group reported no remaining Gossamer Bio position as of Q3 2024 after selling out during the quarter.
  • Artal Group sold 13,308,968 Gossamer Bio shares in Q3 2024, an estimated $12M.
  • Artal Group first reported a position in Gossamer Bio in Q1 2019 and held it in 22 quarters.
  • Artal Group's Gossamer Bio position peaked at $38.9M in Q3 2022.
  • 100 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.